The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.
The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.
In 2018, the apheresis disposables segment accounted for the largest share of the market.
The large share of this segment can be attributed to its recurrent use, increasing blood donations using apheresis devices, increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.
In 2018, the Automated Blood Collection (Donor Apheresis) segment accounted for the largest share of the market.
The large share of this segment can be attributed to the increasing number of blood component donations using apheresis devices and the increasing demand for source plasma from biopharmaceutical companies.
In 2018, the centrifugation segment accounted for the largest share of the market.
The large share of this segment can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components.
In 2018, the plasmapheresis segment accounted for the largest share of the market.
The large share of this segment can be attributed to the increasing demand for plasma from biopharmaceutical companies and the use of plasmapheresis as a key therapeutic apheresis procedure.
In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market.
The large share of this segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness.
APAC is projected to witness the highest growth during the forecast period.
The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the rapid growth in geriatric population, improving healthcare infrastructure, increasing per capita income of the middle-class population in the region, rising focus of key market players on emerging APAC countries, and the increasing accessibility to a range of products with leading players entering these lucrative geographical regions.
The breakdown of primary participants was as mentioned below:
- By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3-25%
- By Designation: C-level-35%, Director Level-25%, and Others-40%
- By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America-10%, Middle East & Africa-5%
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Apheresis Market Overview
4.2 Europe: Apheresis Market, By Application
4.3 Geographic Snapshot of the Apheresis Market (2018)
4.4 Geographic Mix: Apheresis Market, 2019-2025 (USD Million)
4.5 Apheresis Market: Developing vs. Developed Markets, 2019 vs. 2025 (USD Million)
5 Market Overview
5.2 Market Dynamics: Impact Analysis
18.104.22.168 Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases
22.214.171.124 Increasing Demand for Source Plasma From Biopharmaceutical Companies
126.96.36.199 Rising Demand for Blood Components and Growing Concerns Regarding Blood Safety
188.8.131.52 Increase in the Number of Complex Surgical Procedures
184.108.40.206 Favorable Reimbursement for Apheresis Procedures
220.127.116.11 High Cost of Apheresis Devices & Therapeutic Apheresis Procedures and Installation of Apheresis Devices Through Rental Model
18.104.22.168 Fewer Blood Donations Using Apheresis Due to Lack of Awareness
22.214.171.124 Stringent Donor Recruitment Criteria
126.96.36.199 Apheresis for Leukemia and Pediatric Patients
188.8.131.52 Emerging Economies With Increasing Investments From Government Bodies and Leading Players
184.108.40.206 Recruitment of Voluntary Non-Remunerated Donors
220.127.116.11 Safety of Blood Transfusion in Developing Countries
6 Industry Insights
6.1 Industry Trends
6.1.1 New Indications for Plasma Products
6.1.2 Increasing Number of Collaborations, Agreements, and Partnerships
6.2 Porter's Five Force Analysis
6.3 Regulatory Analysis
7 Apheresis Market, By Product
7.2 Apheresis Disposables
7.3 Apheresis Devices
8 Apheresis Market, By Procedure
8.2 Automated Blood Collection (Donor Apheresis)
8.2.1 Increasing Number of Blood Component Donations Using Apheresis Devices to Support Market Growth
8.3 Therapeutic Apheresis
8.3.1 Therapeutic Apheresis Disposables
18.104.22.168 Neurological Disorders
22.214.171.124 Blood Disorders
126.96.36.199 Renal Disorders
188.8.131.52 Autoimmune Disorders
184.108.40.206 Metabolic Disorders
220.127.116.11 Cardiovascular Disorders
18.104.22.168 Other Disorders
8.3.2 Therapeutic Apheresis Devices
22.214.171.124 Centrifugation-Based Devices are One of the Most Commonly Adopted Therapeutic Apheresis Devices
9 Apheresis Market, By Technology
9.2.1 Continuous Flow Centrifugation
9.2.2 Intermittent Flow Centrifugation
9.3 Membrane Separation
9.3.1 Higher Efficacy of This Technology Accounts for Its High Usage in Developed Western European Countries and Japan
10 Apheresis Market, By Application
10.7 Other Applications
11 Apheresis Market, By End User
11.2 Blood Collection Centers & Blood Component Providers
11.2.1 Blood Collection Centers and Blood Component Providers Hold A Major Share of the Apheresis Market
11.3 Hospitals and Transfusion Centers
11.3.1 Hospitals and Transfusion Centers Segment is Expected to Grow at the Highest CAGR During the Forecast Period
11.4 Other End Users
12 Apheresis Market, By Region
12.2 North America
126.96.36.199 The US Dominates the North American Apheresis Market
188.8.131.52 The Demand for Plasma Protein Products in Canada is on the Rise, Which is A Key Factor Driving Market Growth
12.4 Asia Pacific
12.5 Latin America
12.6 Middle East & Africa
13 Competitive Landscape
13.2 Market Share Analysis
13.3 Competitive Leadership Mapping
13.4 Competitive Situation and Trends
14 Company Profiles
14.1 Terumo BCT, Inc.
14.2 Fresenius Se & Co. KGaA
14.3 Haemonetics Corporation
14.4 Baxter International Inc.
14.5 Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)
14.6 B. Braun Melsungen AG
14.7 Cerus Corporation
14.8 Kaneka Corporation
14.9 Kawasumi Laboratories, Inc.
14.10 Nikkiso Co., Ltd.
14.11 Macopharma SA
14.12 Miltenyi Biotec
14.13 Otsuka Holdings Co., Ltd.
14.14 Medica Spa
14.15 Mallinckrodt Plc
14.16 Medicap Clinic GmbH
14.17 LMB Technologie GmbH
14.18 Bioelettronica Srl
14.20 Cytosorbents Corporation
14.21 Toray Medical Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/bob8zr
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900